Varasteh Kia, Mujan
Lau, Brandyn D.
Owodunni, Oluwafemi P.
Kraus, Peggy S.
Holzmueller, Christine G.
Hobson, Deborah B.
Shaffer, Dauryne L.
Streiff, Michael B.
Haut, Elliott R. http://orcid.org/0000-0001-7075-771X
Article History
Accepted: 10 January 2021
First Online: 28 January 2021
Compliance with ethical standards
:
: Drs. Haut and Streiff, Ms. Holzmueller, Ms. Shaffer and Mr. Lau were supported by contracts from PCORI entitled "Preventing Venous Thromboembolism: Empowering Patients and Enabling Patient-Centered Care via Health Information Technology" (CE-12-11-4489) and "Preventing Venous Thromboembolism (VTE): Engaging Patients to Reduce Preventable Harm from Missed/Refused Doses of VTE Prophylaxis" (DI-1603-34596) and Implementing Best-Practice, Patient-Centered Venous Thromboembolism (VTE) Prevention in Trauma Centers" (DI-2019C3-17859). Mr. Lau, Ms. Varasteh Kia, Ms. Holzmueller, Ms. Shaffer, and Drs. Streiff, Haut, and Owodunni were/are supported by a grant from the AHRQ (1R01HS024547) entitled "Individualized Performance Feedback on Venous Thromboembolism Prevention Practice," a contract from PCORI entitled "Preventing Venous Thromboembolism (VTE): Engaging Patients to Reduce Preventable Harm from Missed/Refused Doses of VTE Prophylaxis," and a grant from the NIH/NHLBI (R21HL129028) entitled "Analysis of the Impact of Missed Doses of Venous Thromboembolism Prophylaxis." Drs. Haut, Streiff, Owodunni, Mr. Lau, and Ms. Varasteh Kia are supported by a grant from the AHRQ (R18HS025341) titled "Disseminating an Evidence-based Venous Thromboembolism Prevention Bundle." Mr. Lau is supported by the Institute for Excellence in Education Berkheimer Faculty Education Scholar Grant and a contract (AD-1306-03980) from PCORI entitled "Patient Centered Approaches to Collect Sexual Orientation/Gender Identity Information in the Emergency Department." Dr. Haut is supported by a contract from the Patient-Centered Outcomes Research Institute (PCORI), "A Randomized Pragmatic Trial Comparing the Complications and Safety of Blood Clot Prevention Medicines Used in Orthopedic Trauma Patients" (PCS-1511-32745). Dr. Haut is a paid consultant and speaker for the "Preventing Avoidable Venous Thromboembolism—Every Patient, Every Time" VHA/Vizient IMPERATIV® Advantage Performance Improvement Collaborative. Dr. Haut receives royalties from Lippincott, Williams, Wilkins for a book—"Avoiding Common ICU Errors." Dr. Streiff has received research funding from Boehringer-Ingelheim, Janssen, Novo Nordisk, Roche and Sanofi and consulted for Bayer, Janssen, Pfizer and Portola and received honoraria for CME presentations from Bayer and Portola and has given expert witness testimony in various medical malpractice cases. Ms. Hobson and Dr. Kraus have nothing to disclose.
Free to read: This content has been made available to all.